SY
Syros Pharmaceuticals, Inc.
SYRS · OTC
$0.00 +0.00% (+$0.00)
1M +300.00%
Market Cap $9.39K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
0/9Valuation
100 /100
Cheap P/B 0.00x
P/S 0.00x
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 43.12%
Rev. growth 13.01%
FCF growth N/A
Profitability
20 /100
Weak Net margin 1,656.34%
Op. margin 1,298.19%
FCF margin 1,106.87%
Quality
1 /100
Poor ROA 97.86%
Asset turnover 0.06x
ROIC 91.82%
Debt
50 /100
Moderate Current ratio 3.95x
Int. coverage -31.10x
Net debt/EBITDA 0.49x
Stability
42 /100
Moderate Rev. volatility 52.31%
EPS volatility 13.07%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre SYRS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
James E. Bradner
Employees
68
Headquarters
Cambridge
Evenimente viitoare
29 OCT.
Earnings
Upcoming earnings report